<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2011</study_start_year><condition>Colorectal cancer</condition><disease>Colorectal Cancer</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2621130</full_dataset_link><location>Japan</location><study_start_month>7</study_start_month><repository>ECRIN MDR</repository><study_status>Completed</study_status></additional><is_claimable>false</is_claimable><name>Phase II trial of adjuvant mFOLFOX6 after metastasectomy for lung metastasis of colorectal cancer</name><description>Interventions: Fluororacil/l-leucovorin plus oxaliplatin (mFOLFOX6)
Primary outcome(s): 5-year survival rate
Study Design: Single arm Non-randomized</description><dates><creation>2011-07-15</creation></dates><accession>2621130</accession><cross_references><Japan Primary Registries Network>JPRN-UMIN000005693</Japan Primary Registries Network></cross_references></HashMap>